New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond

Non-muscle-invasive bladder cancer (NMIBC) is characterized by a high rate of cure, but also by a non-negligible probability of recurrence and risk progression to muscle-invasive disease. NMIBC management requires a proper local resection and staging, followed by a risk-based treatment with intraves...

Descripción completa

Detalles Bibliográficos
Autores principales: Audisio, Alessandro, Buttigliero, Consuelo, Delcuratolo, Marco Donatello, Parlagreco, Elena, Audisio, Marco, Ungaro, Antonio, Di Stefano, Rosario Francesco, Di Prima, Lavinia, Turco, Fabio, Tucci, Marcello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834622/
https://www.ncbi.nlm.nih.gov/pubmed/35159167
http://dx.doi.org/10.3390/cells11030357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834622/
https://www.ncbi.nlm.nih.gov/pubmed/35159167
http://dx.doi.org/10.3390/cells11030357

Ejemplares similares